Discover
GLUE
Monte Rosa Therapeutics, Inc.
24.02
2 x 17.86
2 x 30.87
bid
ask
-
0.18
0.74%
2 @ 04:55 AM
24.05 +0.03 (0.12%)
| Ytd | 53.19% | |
| 1y | 421.04% |
23.78
day range
25.03
4.12
52 week range
25.77
| Open | 23.85 | Prev Close | 24.20 | Low | 23.78 | High | 25.03 | Mkt Cap | 2.03B |
| Vol | 1.30M | Avg Vol | 1.09M | EPS | -1.48 | P/E | N/A | Forward P/E | -13.34 |
| Beta | 1.60 | Short Ratio | 18.14 | Inst. Own | 112.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 19.26 | 200-d Avg | 16.53 | 1yr Est | 32.33 |
GLUE News
benzinga.com
Guggenheim Maintains Buy on Monte Rosa Therapeutics, Raises Price Target to $35
Guggenheim analyst Michael Schmidt maintains Monte Rosa Therapeutics (NASDAQ:GLUE) with a Buy and
fool.com
After a 400% Surge, Should Investors Care About This $882,000 Monte Rosa Insider Sale?
This clinical-stage biotech focused on precision medicines reported a notable insider sale amid a ye